{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:03:59Z","timestamp":1774641839439,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["23XD1423100"],"award-info":[{"award-number":["23XD1423100"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["23XD1423100"],"award-info":[{"award-number":["23XD1423100"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241221"],"award-info":[{"award-number":["82241221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatoblastoma (HB) is the most common pediatric liver tumor, presenting significant therapeutic challenges due to its high rates of recurrence and metastasis. While Inosine Monophosphate Dehydrogenase 2(IMPDH2) has been associated with cancer progression, its specific role and clinical implications in HB have not been fully elucidated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study utilized Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) and Tissue Microarray (TMA) for validation. Following this, IMPDH2 was suppressed, and a series of in vitro assays were conducted. Flow cytometry was employed to assess apoptosis and cell cycle arrest. Additionally, the study explored the synergistic therapeutic effects of mycophenolate mofetil (MMF) and doxorubicin (DOX) on HB cell lines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study identified a marked overexpression of IMPDH2 in HB tissues, which was strongly correlated with reduced Overall Survival (OS) and Event-Free Survival (EFS). IMPDH2 upregulation was also found to be associated with key clinical-pathological features, including pre-chemotherapy alpha-fetoprotein (AFP) levels, presence of preoperative metastasis, and the pre-treatment extent of tumor (PRETEXT) staging system. Knockdown of IMPDH2 significantly inhibited HB cell proliferation and tumorigenicity, inducing cell cycle arrest at the G0\/G1 phase. Notably, the combination of MMF, identified as a specific IMPDH2 inhibitor, with DOX, substantially enhanced the therapeutic response.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The overexpression of IMPDH2 was closely linked to adverse outcomes in HB patients and appeared to accelerate cell cycle progression. These findings suggest that IMPDH2 may serve as a valuable prognostic indicator and a potential therapeutic target for HB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p>The present study unveiled a significant overexpression of inosine monophosphate dehydrogenase 2 (IMPDH2) in hepatoblastoma (HB) tissues, particularly in association with metastasis and recurrence of the disease. The pronounced upregulation of IMPDH2 was found to be intimately correlated with adverse outcomes in HB patients. This overexpression appears to accelerate the progression of the cell cycle, suggesting that IMPDH2 may serve as a promising candidate for both a prognostic marker and a therapeutic target in the context of HB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-024-05858-4","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T04:08:36Z","timestamp":1722485316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma"],"prefix":"10.1007","volume":"150","author":[{"given":"Linman","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June-kong","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zicheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"5858_CR35","doi-asserted-by":"crossref","unstructured":"Angelico R, Grimaldi C, Gazia C, Saffioti MC, Manzia TM, Castellano A, Spada M (2019) How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature Cancers (Basel), 11(11)","DOI":"10.3390\/cancers11111693"},{"key":"5858_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2018.10.013","volume":"106","author":"DC Aronson","year":"2019","unstructured":"Aronson DC, Weeda VB, Maibach R, Czauderna P, Dall\u2019Igna P, de Ville de J, Goyet S, Branchereau G, Perilongo P, Brock J, Zsiros M, Semeraro C, Chardot B, Wildhaber B, Morland, Brugi\u00e8res L (2019) Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. Eur J Cancer 106:126\u2013132","journal-title":"Eur J Cancer"},{"issue":"2","key":"5858_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3727\/105221616X693639","volume":"17","author":"D Bell","year":"2017","unstructured":"Bell D, Ranganathan S, Tao J, Monga SP (2017) Novel advances in understanding of Molecular Pathogenesis of Hepatoblastoma: a Wnt\/\u03b2-Catenin perspective. Gene Expr 17(2):141\u2013154","journal-title":"Gene Expr"},{"issue":"20","key":"5858_CR16","first-page":"5826","volume":"52","author":"FR Collart","year":"1992","unstructured":"Collart FR, Chubb CB, Mirkin BL, Huberman E (1992) Increased inosine-5\u2019-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Cancer Res 52(20):5826\u20135828","journal-title":"Cancer Res"},{"issue":"1","key":"5858_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","volume":"26","author":"P Czauderna","year":"2014","unstructured":"Czauderna P, Lopez-Terrada D, Hiyama E, H\u00e4berle B, Malogolowkin MH, Meyers RL (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26(1):19\u201328","journal-title":"Curr Opin Pediatr"},{"issue":"9","key":"5858_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jpedsurg.2004.05.020","volume":"39","author":"JQ Davies","year":"2004","unstructured":"Davies JQ, de la Hall PM, Kaschula RO, Sinclair-Smith CC, Hartley P, Rode H, Millar AJ (2004) Hepatoblastoma\u2013evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases. J Pediatr Surg 39(9):1321\u20131327","journal-title":"J Pediatr Surg"},{"issue":"4","key":"5858_CR5","doi-asserted-by":"publisher","first-page":"E555","DOI":"10.1002\/ijc.27351","volume":"131","author":"S de Fine Licht","year":"2012","unstructured":"de Fine Licht S, Schmidt LS, Rod NH, Schmiegelow K, L\u00e4hteenm\u00e4ki PM, Kogner P, Tr\u00e4ger C, Stokland T, Sch\u00fcz J (2012) Hepatoblastoma in the nordic countries. Int J Cancer 131(4):E555\u2013E561","journal-title":"Int J Cancer"},{"issue":"1","key":"5858_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13046-018-0980-3","volume":"37","author":"S Duan","year":"2018","unstructured":"Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J (2018) IMPDH2 promotes colorectal cancer progression through activation of the PI3K\/AKT\/mTOR and PI3K\/AKT\/FOXO1 signaling pathways. J Exp Clin Cancer Res 37(1):304","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"5858_CR18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/modpathol.3800937","volume":"20","author":"J Fellenberg","year":"2007","unstructured":"Fellenberg J, Bernd L, Delling G, Witte D, Zahlten-Hinguranage A (2007) Prognostic significance of drug-regulated genes in high-grade osteosarcoma. Mod Pathol 20(10):1085\u20131094","journal-title":"Mod Pathol"},{"key":"5858_CR32","doi-asserted-by":"crossref","unstructured":"Gao G, Xue Q, He J, Wu M, Jiang Y, Li Q, Zhang Y, Shi W (2023) Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K\/AKT\/mTOR signaling pathway. Int Immunopharmacol, 125(Pt A): p. 111125","DOI":"10.1016\/j.intimp.2023.111125"},{"issue":"8","key":"5858_CR24","first-page":"639","volume":"1","author":"AL Gartel","year":"2002","unstructured":"Gartel AL, Tyner AL (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1(8):639\u2013649","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"5858_CR33","doi-asserted-by":"publisher","first-page":"e28350","DOI":"10.1002\/pbc.28350","volume":"67","author":"B Haeberle","year":"2020","unstructured":"Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O\u2019Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, von Schweinitz D, Ranganathan S, Yoshimura K, Hishiki T, Tanaka Y, Piao J, Feng Y, Rinaldi E, Saraceno D, Derosa M, Meyers RL (2020) The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: analysis from the children\u2019s hepatic tumors international collaboration (CHIC) database. Pediatr Blood Cancer 67(8):e28350","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"5858_CR38","first-page":"1604","volume":"8","author":"Y He","year":"2018","unstructured":"He Y, Zheng Z, Xu Y, Weng H, Gao Y, Qin K, Rong J, Chen C, Yun M, Zhang J, Ye S (2018) Over-expression of IMPDH2 is associated with tumor progression and poor prognosis in hepatocellular carcinoma. Am J Cancer Res 8(8):1604\u20131614","journal-title":"Am J Cancer Res"},{"issue":"4","key":"5858_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.canep.2013.03.004","volume":"37","author":"JE Heck","year":"2013","unstructured":"Heck JE, Meyers TJ, Lombardi C, Park AS, Cockburn M, Reynolds P, Ritz B (2013) Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol 37(4):390\u2013395","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"5858_CR34","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1111\/ajco.13421","volume":"17","author":"H Hu","year":"2021","unstructured":"Hu H, Zhang W, Wang Y, Zhang Y, Yi Y, Gao Y, Chen L, Huang D (2021) Prognostic analysis for children with hepatoblastoma with lung metastasis: a single-center analysis of 98 cases. Asia Pac J Clin Oncol 17(5):e191\u2013e200","journal-title":"Asia Pac J Clin Oncol"},{"issue":"5","key":"5858_CR21","doi-asserted-by":"publisher","first-page":"e24416","DOI":"10.1002\/jcla.24416","volume":"36","author":"X Jia","year":"2022","unstructured":"Jia X, Liu Y, Cheng Y, Wang Y, Kang H, Ma Z, Chen K (2022) Inosine monophosphate dehydrogenase type1 sustains tumor growth in hepatocellular carcinoma. J Clin Lab Anal 36(5):e24416","journal-title":"J Clin Lab Anal"},{"issue":"8","key":"5858_CR41","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41556-019-0363-9","volume":"21","author":"S Kofuji","year":"2019","unstructured":"Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O, Ikeda Y, Warren M, Sakamoto N, Kitahara S, Yoshino H, Yamashita D, Sumita K, Wolfe K, Lange L, Ikeda S, Shimada H, Minami N, Malhotra A, Morioka S, Ban Y, Asano M, Flanary VL, Ramkissoon A, Chow LML, Kiyokawa J, Mashimo T, Lucey G, Mareninov S, Ozawa T, Onishi N, Okumura K, Terakawa J, Daikoku T, Wise-Draper T, Majd N, Kofuji K, Sasaki M, Mori M, Kanemura Y, Smith EP, Anastasiou D, Wakimoto H, Holland EC, Yong WH, Horbinski C, Nakano I, DeBerardinis RJ, Bachoo RM, Mischel PS, Yasui W, Suematsu M, Saya H, Soga T, Grummt I, Bierhoff H, Sasaki AT (2019) IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nat Cell Biol 21(8):1003\u20131014","journal-title":"Nat Cell Biol"},{"issue":"2","key":"5858_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cncr.23169","volume":"112","author":"AM Linabery","year":"2008","unstructured":"Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the U.S. (1992\u20132004). Cancer 112(2):416\u2013432","journal-title":"Cancer"},{"issue":"9038","key":"5858_CR25","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(96)10310-X","volume":"348","author":"JJ Lipsky","year":"1996","unstructured":"Lipsky JJ (1996) Mycophenolate mofetil. Lancet 348(9038):1357\u20131359","journal-title":"Lancet"},{"issue":"3","key":"5858_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.clinre.2017.12.006","volume":"42","author":"JJG Marin","year":"2018","unstructured":"Marin JJG, Briz O, Herraez E, Lozano E, Asensio M, Di Giacomo S, Romero MR, Osorio-Padilla LM, Santos-Llamas AI, Serrano MA, Armengol C, Efferth T, Macias RIR (2018) Molecular bases of the poor response of liver cancer to chemotherapy. Clin Res Hepatol Gastroenterol 42(3):182\u2013192","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"5858_CR23","doi-asserted-by":"crossref","unstructured":"Mauro M, Rego MA, Boisvert RA, Esashi F, Cavallo F, Jasin M, Howlett NG (2012) p21 promotes error-free replication-coupled DNA double-strand break repair Nucleic Acids Res, 40(17): pp. 8348-60","DOI":"10.1093\/nar\/gks612"},{"issue":"1","key":"5858_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E, H\u00e4berle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children\u2019s hepatic tumors international collaboration. Lancet Oncol 18(1):122\u2013131","journal-title":"Lancet Oncol"},{"issue":"7","key":"5858_CR11","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","volume":"148","author":"SP Monga","year":"2015","unstructured":"Monga SP (2015) \u03b2-Catenin signaling and roles in Liver Homeostasis, Injury, and Tumorigenesis. Gastroenterology 148(7):1294\u20131310","journal-title":"Gastroenterology"},{"issue":"9","key":"5858_CR15","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1016\/S0021-9258(19)34120-1","volume":"265","author":"Y Natsumeda","year":"1990","unstructured":"Natsumeda Y, Ohno S, Kawasaki H, Konno Y, Weber G, Suzuki K (1990) Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem 265(9):5292\u20135295","journal-title":"J Biol Chem"},{"issue":"6","key":"5858_CR42","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.7150\/ijbs.77150","volume":"19","author":"C Ni","year":"2023","unstructured":"Ni C, Liu W, Zheng K, Guo S, Song B, Jing W, Li G, Li B, Ni C, Shi K, Jin G, Yu G (2023) PI3K\/ c-Myc\/AFF4 axis promotes pancreatic tumorigenesis through fueling nucleotide metabolism. Int J Biol Sci 19(6):1968\u20131982","journal-title":"Int J Biol Sci"},{"issue":"3","key":"5858_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1742-4658.2004.04504.x","volume":"272","author":"S Pe\u00f1uelas","year":"2005","unstructured":"Pe\u00f1uelas S, No\u00e9 V, Ciudad CJ (2005) Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells. Febs j 272(3):696\u2013710","journal-title":"Febs j"},{"issue":"6","key":"5858_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/00007691-199512000-00023","volume":"17","author":"JT Ransom","year":"1995","unstructured":"Ransom JT (1995) Mechanism of action of mycophenolate mofetil. Ther Drug Monit 17(6):681\u2013684","journal-title":"Ther Drug Monit"},{"key":"5858_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","volume":"13","author":"JO Russell","year":"2018","unstructured":"Russell JO, Monga SP (2018) Wnt\/\u03b2-Catenin signaling in Liver Development, Homeostasis, and Pathobiology. Annu Rev Pathol 13:351\u2013378","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"5858_CR39","first-page":"1230","volume":"144","author":"JM Shireman","year":"2021","unstructured":"Shireman JM, Atashi F, Lee G, Ali ES, Saathoff MR, Park CH, Savchuk S, Baisiwala S, Miska J, Lesniak MS, James CD, Stupp R, Kumthekar P, Horbinski CM, Ben-Sahra I, Ahmed AU (2021) De novo Purine Biosynth is Major Driv Chemoresistance Glioblastoma Brain 144(4):1230\u20131246","journal-title":"De novo Purine Biosynth is Major Driv Chemoresistance Glioblastoma Brain"},{"issue":"2","key":"5858_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/med.20104","volume":"28","author":"Q Shu","year":"2008","unstructured":"Shu Q, Nair V (2008) Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery. Med Res Rev 28(2):219\u2013232","journal-title":"Med Res Rev"},{"issue":"5","key":"5858_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s004670050359","volume":"11","author":"M Suthanthiran","year":"1997","unstructured":"Suthanthiran M, Strom TB (1997) Immunoregulatory drugs: mechanistic basis for use in organ transplantation. Pediatr Nephrol 11(5):651\u2013657","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"5858_CR28","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/pbc.24219","volume":"59","author":"AD Trobaugh-Lotrario","year":"2012","unstructured":"Trobaugh-Lotrario AD, Katzenstein HM (2012) Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies. Pediatr Blood Cancer 59(5):809\u2013812","journal-title":"Pediatr Blood Cancer"},{"key":"5858_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21037\/tgh.2016.04.01","volume":"1","author":"AD Trobaugh-Lotrario","year":"2016","unstructured":"Trobaugh-Lotrario AD, Meyers RL, Tiao GM, Feusner JH (2016) Pediatric liver transplantation for hepatoblastoma. Transl Gastroenterol Hepatol 1:44","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"3","key":"5858_CR7","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1542\/peds.2015-0224","volume":"136","author":"M Tulla","year":"2015","unstructured":"Tulla M, Berthold F, Graf N, Rutkowski S, von Schweinitz D, Spix C, Kaatsch P (2015) Incidence, trends, and survival of children with embryonal tumors. Pediatrics 136(3):e623\u2013e632","journal-title":"Pediatrics"},{"issue":"6","key":"5858_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P","volume":"74","author":"D von Schweinitz","year":"1997","unstructured":"von Schweinitz D, Hecker H, Schmidt-von-Arndt G, Harms D (1997) Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer 74(6):593\u2013599","journal-title":"Int J Cancer"},{"issue":"1","key":"5858_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ptr.6825","volume":"35","author":"W Wang","year":"2021","unstructured":"Wang W, Wu Y, Chen S, Liu X, He J, Wang S, Lu W, Tang Y, Huang J (2021) Shikonin is a novel and selective IMPDH2 inhibitor that target triple-negative breast cancer. Phytother Res 35(1):463\u2013476","journal-title":"Phytother Res"},{"issue":"6456","key":"5858_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/366701a0","volume":"366","author":"Y Xiong","year":"1993","unstructured":"Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) 21 is a universal inhibitor of cyclin kinases. Nature 366(6456):701\u2013704","journal-title":"Nature"},{"issue":"5","key":"5858_CR19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.surg.2014.05.012","volume":"156","author":"LY Yang","year":"2014","unstructured":"Yang LY, Chang RM, Lau WY, Ou DP, Wu W, Zeng ZJ (2014) Mesohepatectomy for centrally located large hepatocellular carcinoma: indications, techniques, and outcomes. Surgery 156(5):1177\u20131187","journal-title":"Surgery"},{"issue":"10","key":"5858_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s12094-014-1167-9","volume":"16","author":"L Zhou","year":"2014","unstructured":"Zhou L, Xia D, Zhu J, Chen Y, Chen G, Mo R, Zeng Y, Dai Q, He H, Liang Y, Jiang F, Zhong W (2014) Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer. Clin Transl Oncol 16(10):906\u2013913","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"5858_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12032-014-0373-1","volume":"32","author":"J Zou","year":"2015","unstructured":"Zou J, Han Z, Zhou L, Cai C, Luo H, Huang Y, Liang Y, He H, Jiang F, Wang C, Zhong W (2015) Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer. Med Oncol 32(1):373","journal-title":"Med Oncol"},{"key":"5858_CR30","doi-asserted-by":"crossref","unstructured":"Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G (2013) Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study Lancet Oncol, 14(9): pp. 834\u2009\u2013\u200942","DOI":"10.1016\/S1470-2045(13)70272-9"},{"issue":"15","key":"5858_CR29","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","volume":"28","author":"J Zs\u00edros","year":"2010","unstructured":"Zs\u00edros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G (2010) Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 28(15):2584\u20132590","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05858-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05858-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05858-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T19:03:32Z","timestamp":1727377412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05858-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["5858"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05858-4","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}